The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Abeona Therapeutics Inc | COM | 00289Y107 | 37,402 | 2,359,767 | SH | SOLE | 2,359,767 | 0 | 0 | ||
| Advaxis Inc. | W EXP 07/15/201 | 007624117 | 113 | 112,500 | SH | SOLE | 112,500 | 0 | 0 | ||
| Aldeyra Therapeutics Inc | COM | 01438T106 | 844 | 124,096 | SH | SOLE | 124,096 | 0 | 0 | ||
| Ampio Pharmaceuticals Inc. | COM | 03209T109 | 10,564 | 2,595,484 | SH | SOLE | 2,595,484 | 0 | 0 | ||
| Anavex Life Sciences Corp | COM NEW | 032797300 | 2,332 | 724,205 | SH | SOLE | 724,205 | 0 | 0 | ||
| Biohaven Pharmactl Hldg Co L | COM | G11196105 | 21,779 | 807,224 | SH | SOLE | 807,224 | 0 | 0 | ||
| Corbus Pharmaceuticals HLDGS | COM | 21833P103 | 27,385 | 3,856,985 | SH | SOLE | 3,856,985 | 0 | 0 | ||
| Evoke Pharma Inc | COM | 30049G104 | 622 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
| Krystal Biotech Inc | COM | 501147102 | 3,156 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| Soligenix Inc. | COM | 834223307 | 1,835 | 870,000 | SH | SOLE | 870,000 | 0 | 0 | ||
| Vascular Biogenics LTD | COM | M96883109 | 6,367 | 896,771 | SH | SOLE | 896,771 | 0 | 0 | ||
| Volition RX LTD | COM | 928661107 | 1,034 | 351,538 | SH | SOLE | 351,538 | 0 | 0 | ||